LGR5 and malignant colon neoplasm: Furthermore, colon cancer cells, namely, HT29, SW620, and SW837 when treated with dinaciclib showed decreased the expression levels for LGR5, ID1, and CD44v9 (Fig. 7B and Supplementary Fig. 7A).